rhIL-7-hyFc (efineptakin alpha; NT-I7) enhances the anti-tumor response when combined with anti-TIGIT or anti-VEGFSeungtae Baek,Sun-Kyoung Im,Minji Lee,Mankyu Ji,Miyoung Kim,Kwang-Hoon Lee, Yun Hee Choi, Won Tae Kim,Donghoon ChoiCANCER RESEARCH(2022)引用 0|浏览0暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要